Laura M Grosso

Summary

Affiliation: Yale University
Country: USA

Publications

  1. ncbi request reprint Caffeine metabolism, genetics, and perinatal outcomes: a review of exposure assessment considerations during pregnancy
    Laura M Grosso
    Yale Center for Perinatal, Pediatric, and Environmental Epidemiology, Yale University School of Medicine, Department of Epidemiology and Public Health, New Haven, CT 06510, USA
    Ann Epidemiol 15:460-6. 2005
  2. ncbi request reprint Caffeine metabolites in umbilical cord blood, cytochrome P-450 1A2 activity, and intrauterine growth restriction
    Laura M Grosso
    Yale Center for Perinatal, Pediatric and Environmental Epidemiology, Yale University, New Haven, CT 06510, USA
    Am J Epidemiol 163:1035-41. 2006
  3. pmc Prenatal caffeine assessment: fetal and maternal biomarkers or self-reported intake?
    Laura M Grosso
    Yale Center for Perinatal, Pediatric and Environmental Epidemiology, Yale University School of Medicine, Department of Epidemiology and Public Health, One Church Street, New Haven, CT 06510, USA
    Ann Epidemiol 18:172-8. 2008
  4. pmc Chocolate consumption in pregnancy and reduced likelihood of preeclampsia
    Elizabeth W Triche
    Yale Center for Perinatal, Pediatric and Environmental Epidemiology, Yale University, New Haven, CT 06510, USA
    Epidemiology 19:459-64. 2008
  5. ncbi request reprint Development of 2 registry-based risk models suitable for characterizing hospital performance on 30-day all-cause mortality rates among patients undergoing percutaneous coronary intervention
    Jeptha P Curtis
    Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA
    Circ Cardiovasc Qual Outcomes 5:628-37. 2012

Detail Information

Publications5

  1. ncbi request reprint Caffeine metabolism, genetics, and perinatal outcomes: a review of exposure assessment considerations during pregnancy
    Laura M Grosso
    Yale Center for Perinatal, Pediatric, and Environmental Epidemiology, Yale University School of Medicine, Department of Epidemiology and Public Health, New Haven, CT 06510, USA
    Ann Epidemiol 15:460-6. 2005
    ....
  2. ncbi request reprint Caffeine metabolites in umbilical cord blood, cytochrome P-450 1A2 activity, and intrauterine growth restriction
    Laura M Grosso
    Yale Center for Perinatal, Pediatric and Environmental Epidemiology, Yale University, New Haven, CT 06510, USA
    Am J Epidemiol 163:1035-41. 2006
    ..21, 95% confidence interval: 1.07, 1.37), suggesting that CYP1A2 activity, and not the absolute levels of paraxanthine, influences fetal growth. No associations were observed between caffeine or any metabolites and preterm delivery...
  3. pmc Prenatal caffeine assessment: fetal and maternal biomarkers or self-reported intake?
    Laura M Grosso
    Yale Center for Perinatal, Pediatric and Environmental Epidemiology, Yale University School of Medicine, Department of Epidemiology and Public Health, One Church Street, New Haven, CT 06510, USA
    Ann Epidemiol 18:172-8. 2008
    ..We sought to examine associations among measures of caffeine exposure, including maternal urine, umbilical cord blood, and maternal self report...
  4. pmc Chocolate consumption in pregnancy and reduced likelihood of preeclampsia
    Elizabeth W Triche
    Yale Center for Perinatal, Pediatric and Environmental Epidemiology, Yale University, New Haven, CT 06510, USA
    Epidemiology 19:459-64. 2008
    ..Preeclampsia is a major pregnancy complication with cardiovascular manifestations. Recent studies suggest that chocolate consumption may benefit cardiovascular health...
  5. ncbi request reprint Development of 2 registry-based risk models suitable for characterizing hospital performance on 30-day all-cause mortality rates among patients undergoing percutaneous coronary intervention
    Jeptha P Curtis
    Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA
    Circ Cardiovasc Qual Outcomes 5:628-37. 2012
    ..To date, however, we lack a methodology to monitor and improve national hospital 30-day mortality rates among patients undergoing PCI...